14:10
#27 Association between stimulation parameters at the time of implantation of Sacral Nerve Stimulator and explantation after successful implantation
Presenter: Yahya Ghazwani
Ghazwani Y1, Elkelini M1, Hassouna M11. Toronto Western Hospital,University Health Network, University of Toronto,Canada
14:15
#28 Patient Age Predicts Success in Patients Undergoing Sacral Neuromodulation for Voiding Dysfunction
Presenter: Charles Powell
Powell C1, Takacs E2, Kreder K11. University of Iowa, 2. Un
14:20
#29 RESULTS OF SACRAL NERVE MODULATION FOR THE TREATMENT OF BLADDER DYSFUNCTIONS IN MULTIPLE SCLEROSIS PATIENTS
Presenter: Elena Andretta
Andretta E1, Ostardo E2, Simeone C3, Signorello D4, Pastorello M5, Campo C6, Limido L6, Bastianello P71. Department of Urology – General Hospital DOLO (Venice), 2. Department of Urology – City Hospital “S.ta Maria degli Angeli” PORDENONE, 3. Department of Urology – University BRESCIA, 4. Department of Urology – General Hospital BOLZANO, 5. Department of Urology – Sacro Cuore Hospital NEGRAR (VERONA), 6. Medtronic Italia, 7. Department of Urology - General Hospital DOLO (Venice)
14:25
#30 IMPACT OF CONVENIENCE VOID IN BLADDER DIARY WHICH INVOLVES SELF-REPORTED URINARY PERCEPTION TO ASSESS BLADDER SENSITIVITY
Presenter: Hisashi Honjo
Honjo H1, Ukimura O2, Kawauchi A2, Kitakoji H3, Nakao M3, Miki T21. Meiji University of Integrative Medicine, Kyoto Prefectural University of Medicine, 2. Kyoto Prefectural University of Medicine, 3. Meiji University of Integrative Medicine
14:30
#31 Attitudes of women with multiple sclerosis when questioned about genital touching and continence device placement
Presenter: Doreen McClurg
McClurg D1, Hagen S11. Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University
14:35
#32 The possible role of opiates in women with urinary retention- Observations from a prospective clinical study
Presenter: Jalesh Panicker
Panicker J1, Khan S1, Kessler T2, Gonzales G1, Haslam C1, Elneil S1, Fowler C11. Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, 2. Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery and Department of Urology, University of Bern, 3010 Bern, Bern, Switzerland
14:40
#33 EFFICACY OF BOTULINUM TOXIN A INJECTION FOR NEUROGENIC DETRUSOR OVERACTIVITY AND URINARY INCONTINENCE – A RANDOMIZED DOUBLE-BLIND TRIAL Best Clinical Presentation
Presenter: Sender Herschorn
Herschorn S1, Gajewski J2, Ethans K3, Corcos J4, Carlson K5, Bailly G2, Bard R3, Valiquette L6, Baverstock R5, Radomski S1, Carr L11. University of Toronto, 2. Dalhousie University, 3. University of Manitoba, 4. McGill University, 5. University of Calgary, 6. University of Montreal
14:45
#34 Can 100 units of botulinum toxin A preserve the ability of voluntary voiding and improve overactive bladder symptoms in patients suffering from multiple sclerosis?
Presenter: Ulrich Mehnert
Birzele J1, Mehnert U2, Reuter K2, Schurch B21. Kantonsspital Graubuenden, Urology, Chur, Switzerland, 2. Spinal Cord Injury Center, Balgrist University Hospital, Dept. of Neurourology, Zurich, Switzerland
14:50
#35 Effects of repeated Botulinum toxin A injection therapy in patients with sympthomatic neurogenic detrusor overactivity – a 3-year follow up
Presenter: Lars Malmberg
Malmberg L1, Karadzic V11. Dept of Urology, Lund University Hospital, Sweden
14:55
#36 THE EFFECT OF DEEP BRAIN STIMULATION ON VOIDING DYSFUNCTION IN PARKINSON’S DISEASE AND ESSENTIAL TREMOR
Presenter: Bhavin Patel
Vishwajit S1, Patel B1, Herco M1, Siddiqui M1, Cartwright M1, Badlani G11. Wake Forest University Baptist Medical Center
15:00
#37 THE INCIDENCE OF VOIDING DIFFICULITY AND CONSTIPATION IN PATIENTS WITH ESSENTIAL TREMOR COMPARED TO PARKINSON’S DISEASE
15:05
#38 IS EARLY PROPHYLACTIC INTERVENTION BENEFICIAL FOR THE MANAGEMENT OF THE LOWER URINARY TRACT DYSFUNCTION IN CHILDREN WITH SPINA BIFIDA?
Presenter: Midori Ichino
Ichino M1, Igawa Y1, Ogawa T1, Seki S2, Ishizuka O1, Nishizawa O11. Department of urology Shinshu-university school of medicine, 2. Seki Urological clinic
15:10
#39 Voiding dysfunction in patients with dysautonomia
Presenter: Anand Shridharani
Shridharani A1, Guralnick M1, Barboi A1, Jaradeh S1, Prieto T1, Yellick M1, O'Connor R C11. Medical College of Wisconsin
15:15
#40 Evaluation of Renal Function by Serum Cystatin C for the Patient with Neurogenic Bladder having a Central Nerve System Disorder
Presenter: Mori Ken-ichi
Ken-ichi M1, Noguchi M1, Hatada T1, Takahashi H1, Matsuo M11. Nagasaki University Graduate School Of Biomedical Sciences, Division Of Nephro-Urology
15:20
#41 Do Patients with a Small Prostate Volume Differ Urodynamically from Those with a Larger Prostate Volume?
Presenter: Sung-Yong Cho
Cho S1, Kang M1, Yi J1, Oh S11. Seoul National University Hospital
15:25
#42 Urethral Innervation Better in Continent Women than Stress Incontinent Women
Presenter: Kimberly Kenton
Kenton K1, Brubaker L1, Mueller E11. Loyola University Medical Center